S2k guideline on diagnosis and treatment of atopic dermatitis - short version

Standard

S2k guideline on diagnosis and treatment of atopic dermatitis - short version. / Werfel, Thomas; Heratizadeh, Annice; Aberer, Werner; Ahrens, Frank; Augustin, Matthias; Biedermann, Tilo; Diepgen, Thomas; Fölster-Holst, Regina; Gieler, Uwe; Kahle, Julia; Kapp, Alexander; Nast, Alexander; Nemat, Katja; Ott, Hagen; Przybilla, Bernhard; Roecken, Martin; Schlaeger, Martin; Schmid-Grendelmeier, Peter; Schmitt, Jochen; Schwennesen, Thomas; Staab, Doris; Worm, Margitta.

In: Allergo J Int, Vol. 25, No. 3, 31.05.2016, p. 82-95.

Research output: SCORING: Contribution to journalOther (editorial matter etc.)Research

Harvard

Werfel, T, Heratizadeh, A, Aberer, W, Ahrens, F, Augustin, M, Biedermann, T, Diepgen, T, Fölster-Holst, R, Gieler, U, Kahle, J, Kapp, A, Nast, A, Nemat, K, Ott, H, Przybilla, B, Roecken, M, Schlaeger, M, Schmid-Grendelmeier, P, Schmitt, J, Schwennesen, T, Staab, D & Worm, M 2016, 'S2k guideline on diagnosis and treatment of atopic dermatitis - short version', Allergo J Int, vol. 25, no. 3, pp. 82-95. https://doi.org/10.1007/s40629-016-0110-8

APA

Werfel, T., Heratizadeh, A., Aberer, W., Ahrens, F., Augustin, M., Biedermann, T., Diepgen, T., Fölster-Holst, R., Gieler, U., Kahle, J., Kapp, A., Nast, A., Nemat, K., Ott, H., Przybilla, B., Roecken, M., Schlaeger, M., Schmid-Grendelmeier, P., Schmitt, J., ... Worm, M. (2016). S2k guideline on diagnosis and treatment of atopic dermatitis - short version. Allergo J Int, 25(3), 82-95. https://doi.org/10.1007/s40629-016-0110-8

Vancouver

Bibtex

@article{92d0d704debd40d0a2279c25d9f3ecb5,
title = "S2k guideline on diagnosis and treatment of atopic dermatitis - short version",
abstract = "Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).",
keywords = "Review, Journal Article",
author = "Thomas Werfel and Annice Heratizadeh and Werner Aberer and Frank Ahrens and Matthias Augustin and Tilo Biedermann and Thomas Diepgen and Regina F{\"o}lster-Holst and Uwe Gieler and Julia Kahle and Alexander Kapp and Alexander Nast and Katja Nemat and Hagen Ott and Bernhard Przybilla and Martin Roecken and Martin Schlaeger and Peter Schmid-Grendelmeier and Jochen Schmitt and Thomas Schwennesen and Doris Staab and Margitta Worm",
note = "Behandlungsleitlinie",
year = "2016",
month = may,
day = "31",
doi = "10.1007/s40629-016-0110-8",
language = "English",
volume = "25",
pages = "82--95",
journal = "Allergo J Int",
issn = "2197-0378",
publisher = "Springer Medizin",
number = "3",

}

RIS

TY - JOUR

T1 - S2k guideline on diagnosis and treatment of atopic dermatitis - short version

AU - Werfel, Thomas

AU - Heratizadeh, Annice

AU - Aberer, Werner

AU - Ahrens, Frank

AU - Augustin, Matthias

AU - Biedermann, Tilo

AU - Diepgen, Thomas

AU - Fölster-Holst, Regina

AU - Gieler, Uwe

AU - Kahle, Julia

AU - Kapp, Alexander

AU - Nast, Alexander

AU - Nemat, Katja

AU - Ott, Hagen

AU - Przybilla, Bernhard

AU - Roecken, Martin

AU - Schlaeger, Martin

AU - Schmid-Grendelmeier, Peter

AU - Schmitt, Jochen

AU - Schwennesen, Thomas

AU - Staab, Doris

AU - Worm, Margitta

N1 - Behandlungsleitlinie

PY - 2016/5/31

Y1 - 2016/5/31

N2 - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).

AB - Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).

KW - Review

KW - Journal Article

U2 - 10.1007/s40629-016-0110-8

DO - 10.1007/s40629-016-0110-8

M3 - Other (editorial matter etc.)

C2 - 27239428

VL - 25

SP - 82

EP - 95

JO - Allergo J Int

JF - Allergo J Int

SN - 2197-0378

IS - 3

ER -